CRH Lung Institute
At Columbus Regional Health's Lung Institute, our innovative care and treatment for acute and chronic lung diseases, from lung cancer diagnosis to chronic lung disease management to post-lung cancer treatment care, is unmatched. We do this through our commitment to stay at the forefront of innovation.
For example, The Lung Institute is the only facility in the region with the technology and skill to diagnose lung cancer earlier when lung cancer treatment has the best chance for success. We put all of our diagnosis and lung disease treatment services into one convenient location at Columbus Regional Hospital for coordinated and seamless care for patients.
Many chronic and acute lung diseases hinder the body's life-sustaining ability to breathe. Lung disease is the nation's number three killer, responsible for one in six deaths. That's why the CRH Lung Institute is committed to finding and using the very latest in technology for diagnosing lung diseases at the earliest stages.
Our Lung Institute team, championed by medical director Dr. David Wilson, can diagnose and manage the full range of lung diseases including lung cancer, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Pulmonary Hypertension.
Lung Disease Treatment Services:
Lung Cancer: It used to be that diagnosing lung abnormalities found on a CT scan or chest X-ray required a surgical biopsy. This caused many patients to hesitate, possibly delaying important diagnoses. The Lung Institute's Dr. David Wilson was one of the first cancer specialists in the country to use endoscopic Cellvizio technology and inReach superDimension electromagnetic navigation bronchoscopy to look deeper into narrow lung passages than traditional bronchoscopy provides. While there, he gathers a small tissue sample to biopsy, making precise diagnosis of the lung possible much earlier than ever before. That's how we're thinking beyond for to diagnose cancer earlier when the potential for cure is highest.
Chronic Obstructive Pulmonary Disease (COPD): Offering pulmonary function testing to diagnose COPD. Then we treat using the most current drug therapy with consideration for pulmonary rehabilitation services.
Asthma: Offering diagnostic testing, new bronchial thermoplasty procedures, individualized management plans, and a Better Breathers support group in conjunction with the American Lung Association for adults with chronic lung disease. The Lung Institute's Dr. David Wilson was the first in Indiana to use the Alair® Bronchial Thermoplasty System to help severe asthma patients can better airway control.
Nitric Oxide Testing: Our Lung Institute is one of only five centers in Indiana to use NIOX MINO for exhaled nitric oxide testing. This monitors airway activity to look for problems, symptoms, and response to asthma treatment. When airways are inflamed related to asthma and other problems, they release more nitric oxide than normal. Testing exhaled nitric oxide means that people with asthma now have a better chance of receiving the best possible treatment.
Pulmonary Hypertension: Providing expert management and the most current drug therapy.